Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2025-12-24 @ 7:12 PM
NCT ID:
NCT07236203
Eligibility Criteria:
Inclusion Criteria:
1. Pathological diagnosis confirmed as large B-cell lymphoma
2. Patients with relapsed or refractory large B-cell lymphoma (R/R DLBCL) after receiving second-line or above systemic treatment
3. Intend to use CAR-T products approved by NMPA for the treatment of R/R LBCL.
4. Understand and voluntarily sign a written informed consent form. For patients without full civil capacity, their guardians must be informed and sign the corresponding informed consent form and note the date, as for the patient himself, informed consent may be obtained based on the specific circumstances.
Exclusion Criteria:
1. Poor patient compliance
2. During pregnancy or lactation
3. After judgment by the researcher, the patient has other unsuitable conditions for inclusion in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07236203
Study Brief:
Protocol Section:
NCT07236203